' Impressive ' New Data on Novel Schizophrenia Hopeful KarXT ' Impressive ' New Data on Novel Schizophrenia Hopeful KarXT
The novel investigational antipsychotic KarXT was effective and well tolerated in adults with schizophrenia experiencing acute psychosis in a second phase 3 trial.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news
More News: Psychiatry | Schizophrenia